Arcus Biosciences, Inc. (RCUS) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Arcus Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.145 -- 00:00:06.334 Hello everyone and welcome to ARCA's Biosciences first quarter 2025 earnings and financial 00:00:06.334 -- 00:00:10.502 results call. My name's Lydia and I'll be your operator today. 00:00:10.502 -- 00:00:13.868 After the prepared remarks, there'll be an opportunity to ask questions. 00:00:13.868 -- 00:00:17.775 If you'd like to participate in the Q&A, you can do so by pressing star followed by one 00:00:17.775 -- 00:00:22.845 on your telephone keypad. I'll now hand you over to Pia Eates, Vice President of Investor 00:00:22.845 -- 00:00:26.488 Relations to begin. Please go ahead. 00:00:26.677 -- 00:00:31.063 Good afternoon, and thank you for joining us on today's conference call to discuss ARGUS's 00:00:31.063 -- 00:00:34.729 first quarter 2025 financial results and pipeline updates. 00:00:34.729 -- 00:00:38.935 I'd like to remind you that on this call, management will make forward-looking statements, 00:00:38.935 -- 00:00:43.762 including statements about our cash runway, our projected 2025 revenue, and our expected 00:00:43.762 -- 00:00:46.606 clinical development milestones and timelines. 00:00:46.606 -- 00:00:50.952 All statements, other than historical facts, reflect the current beliefs and expectations 00:00:50.952 -- 00:00:54.978 of management and involve risks and uncertainties that may cause our actual results to 00:00:54.978 -- 00:00:59.465 differ from those expressed. Those risks and uncertainties are described in our most 00:00:59.465 -- 00:01:04.853 recent quarterly report on Form 10-Q that is filed with the SEC. 00:01:04.853 -- 00:01:10.081 Today you'll hear from our CEO, Terry Rosen, CMO, Richard Marcus, COO, Jennifer Jarrett, 00:01:10.081 -- 00:01:15.188 and CFO, Bob Gels. We'll also be joined by our President, Juan...